Question 9442 — pharmacy and medications

Summary

Mr. Laurent Croizier draws the attention of the Minister to the Minister of Labor, Health, Solidarity and Families, responsible for health and access to care, to the persistent shortage of certain essential medicines. Interviews with patients and health professionals in the MP's constituency report recurring supply difficulties, sometimes total shortages, forcing patients to change their treatment, postpone injections or, in some cases, import these medications at their own expense. These shortages deeply question the national and European capacity to cover the health needs of the population. They reveal a concerning dependence on international supply chains concentrated outside the European Union, whose logic favors profitability over health safety. This is particularly the case for Repatha, prescribed for the reduction of cholesterol in severe forms of hypercholesterolemia, which concerns patients at high cardiovascular risk, often without effective therapeutic alternatives. This is also the case for certain types of insulin, which makes the management of diabetes particularly complex, with immediate risks for the lives of the patients concerned. Also, he asks what actions are being taken to address these drug shortages, particularly for patients with high cholesterol or diabetes, under treatment with Repatha, Praluent alirocumab or insulin.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.